CN115746309B - 一种主链为金属元素的高分子及其制备方法和应用 - Google Patents
一种主链为金属元素的高分子及其制备方法和应用 Download PDFInfo
- Publication number
- CN115746309B CN115746309B CN202211377822.2A CN202211377822A CN115746309B CN 115746309 B CN115746309 B CN 115746309B CN 202211377822 A CN202211377822 A CN 202211377822A CN 115746309 B CN115746309 B CN 115746309B
- Authority
- CN
- China
- Prior art keywords
- ligand
- main chain
- aminopyridine
- polymer
- metal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229910052751 metal Inorganic materials 0.000 title claims abstract description 60
- 239000002184 metal Substances 0.000 title claims abstract description 58
- 229920000642 polymer Polymers 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title abstract description 13
- 239000003446 ligand Substances 0.000 claims abstract description 53
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 23
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 22
- 239000005267 main chain polymer Substances 0.000 claims abstract description 13
- 239000000126 substance Substances 0.000 claims abstract description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 30
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 24
- -1 2-aminoethylphenyl Chemical group 0.000 claims description 20
- 238000006243 chemical reaction Methods 0.000 claims description 18
- 229910052757 nitrogen Inorganic materials 0.000 claims description 15
- 150000003927 aminopyridines Chemical class 0.000 claims description 14
- 150000001875 compounds Chemical class 0.000 claims description 14
- 229910052763 palladium Inorganic materials 0.000 claims description 12
- ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical group NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 claims description 10
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 10
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 10
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Natural products CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 10
- 239000003960 organic solvent Substances 0.000 claims description 10
- 238000006116 polymerization reaction Methods 0.000 claims description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 9
- VTJUKNSKBAOEHE-UHFFFAOYSA-N calixarene Chemical compound COC(=O)COC1=C(CC=2C(=C(CC=3C(=C(C4)C=C(C=3)C(C)(C)C)OCC(=O)OC)C=C(C=2)C(C)(C)C)OCC(=O)OC)C=C(C(C)(C)C)C=C1CC1=C(OCC(=O)OC)C4=CC(C(C)(C)C)=C1 VTJUKNSKBAOEHE-UHFFFAOYSA-N 0.000 claims description 7
- 239000003054 catalyst Substances 0.000 claims description 7
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical group [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 7
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 claims description 6
- 239000000178 monomer Substances 0.000 claims description 6
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 claims description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 5
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 5
- 239000003513 alkali Substances 0.000 claims description 5
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims description 5
- 229910000024 caesium carbonate Inorganic materials 0.000 claims description 5
- 238000001465 metallisation Methods 0.000 claims description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 5
- SLMHHOVQRSSRCV-UHFFFAOYSA-N 2,3-dibromopyridine Chemical compound BrC1=CC=CN=C1Br SLMHHOVQRSSRCV-UHFFFAOYSA-N 0.000 claims description 4
- BKLJUYPLUWUEOQ-UHFFFAOYSA-N 6-bromopyridin-2-amine Chemical compound NC1=CC=CC(Br)=N1 BKLJUYPLUWUEOQ-UHFFFAOYSA-N 0.000 claims description 4
- OBYJTLDIQBWBHM-UHFFFAOYSA-N 6-chloropyridin-2-amine Chemical compound NC1=CC=CC(Cl)=N1 OBYJTLDIQBWBHM-UHFFFAOYSA-N 0.000 claims description 4
- UZALKVXCOUSWSL-UHFFFAOYSA-N 6-fluoropyridin-2-amine Chemical group NC1=CC=CC(F)=N1 UZALKVXCOUSWSL-UHFFFAOYSA-N 0.000 claims description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 4
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 4
- 238000006555 catalytic reaction Methods 0.000 claims description 4
- 238000005859 coupling reaction Methods 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 claims description 4
- 230000002194 synthesizing effect Effects 0.000 claims description 4
- CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical group [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 claims description 3
- FEYDZHNIIMENOB-UHFFFAOYSA-N 2,6-dibromopyridine Chemical group BrC1=CC=CC(Br)=N1 FEYDZHNIIMENOB-UHFFFAOYSA-N 0.000 claims description 3
- 239000002585 base Substances 0.000 claims description 3
- USVZFSNDGFNNJT-UHFFFAOYSA-N cyclopenta-1,4-dien-1-yl(diphenyl)phosphane (2,3-dichlorocyclopenta-1,4-dien-1-yl)-diphenylphosphane iron(2+) Chemical compound [Fe++].c1cc[c-](c1)P(c1ccccc1)c1ccccc1.Clc1c(cc[c-]1Cl)P(c1ccccc1)c1ccccc1 USVZFSNDGFNNJT-UHFFFAOYSA-N 0.000 claims description 3
- 229910052759 nickel Inorganic materials 0.000 claims description 3
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 claims description 3
- 229910052703 rhodium Inorganic materials 0.000 claims description 3
- 239000010948 rhodium Substances 0.000 claims description 3
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 claims description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 claims description 2
- YGGUZZJLGAUOLQ-UHFFFAOYSA-N 6-iodopyridin-2-amine Chemical compound NC1=CC=CC(I)=N1 YGGUZZJLGAUOLQ-UHFFFAOYSA-N 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical group [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 claims description 2
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 150000001340 alkali metals Chemical class 0.000 claims description 2
- GQPLZGRPYWLBPW-UHFFFAOYSA-N calix[4]arene Chemical group C1C(C=2)=CC=CC=2CC(C=2)=CC=CC=2CC(C=2)=CC=CC=2CC2=CC=CC1=C2 GQPLZGRPYWLBPW-UHFFFAOYSA-N 0.000 claims description 2
- 229910052804 chromium Inorganic materials 0.000 claims description 2
- 239000011651 chromium Substances 0.000 claims description 2
- 229910017052 cobalt Inorganic materials 0.000 claims description 2
- 239000010941 cobalt Substances 0.000 claims description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims description 2
- 229910052802 copper Inorganic materials 0.000 claims description 2
- 239000010949 copper Substances 0.000 claims description 2
- WDVGNXKCFBOKDF-UHFFFAOYSA-N dicyclohexyl-[3,6-dimethoxy-2-[2,4,6-tri(propan-2-yl)phenyl]phenyl]phosphane Chemical compound COC1=CC=C(OC)C(C=2C(=CC(=CC=2C(C)C)C(C)C)C(C)C)=C1P(C1CCCCC1)C1CCCCC1 WDVGNXKCFBOKDF-UHFFFAOYSA-N 0.000 claims description 2
- QNLZIZAQLLYXTC-UHFFFAOYSA-N dimethylnaphthalene Natural products C1=CC=CC2=C(C)C(C)=CC=C21 QNLZIZAQLLYXTC-UHFFFAOYSA-N 0.000 claims description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052737 gold Inorganic materials 0.000 claims description 2
- 239000010931 gold Substances 0.000 claims description 2
- 229910052741 iridium Inorganic materials 0.000 claims description 2
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical group [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 2
- MUJIDPITZJWBSW-UHFFFAOYSA-N palladium(2+) Chemical compound [Pd+2] MUJIDPITZJWBSW-UHFFFAOYSA-N 0.000 claims description 2
- 229910052697 platinum Inorganic materials 0.000 claims description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 2
- 229910052709 silver Inorganic materials 0.000 claims description 2
- 239000004332 silver Substances 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 2
- 125000003944 tolyl group Chemical group 0.000 claims description 2
- 239000008096 xylene Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 3
- 125000004429 atom Chemical group 0.000 claims 2
- 230000008878 coupling Effects 0.000 claims 2
- 238000010168 coupling process Methods 0.000 claims 2
- LVEYOSJUKRVCCF-UHFFFAOYSA-N 1,3-bis(diphenylphosphino)propane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)CCCP(C=1C=CC=CC=1)C1=CC=CC=C1 LVEYOSJUKRVCCF-UHFFFAOYSA-N 0.000 claims 1
- 239000003519 biomedical and dental material Substances 0.000 claims 1
- 239000004305 biphenyl Substances 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 230000005693 optoelectronics Effects 0.000 claims 1
- 230000000379 polymerizing effect Effects 0.000 claims 1
- VNFWTIYUKDMAOP-UHFFFAOYSA-N sphos Chemical compound COC1=CC=CC(OC)=C1C1=CC=CC=C1P(C1CCCCC1)C1CCCCC1 VNFWTIYUKDMAOP-UHFFFAOYSA-N 0.000 claims 1
- 229920002521 macromolecule Polymers 0.000 abstract description 9
- 229920001002 functional polymer Polymers 0.000 abstract description 2
- 229910052723 transition metal Inorganic materials 0.000 abstract description 2
- 150000003624 transition metals Chemical class 0.000 abstract description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 238000001819 mass spectrum Methods 0.000 description 12
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 12
- 238000005481 NMR spectroscopy Methods 0.000 description 9
- 238000004949 mass spectrometry Methods 0.000 description 9
- 239000002904 solvent Substances 0.000 description 8
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- FKNQCJSGGFJEIZ-UHFFFAOYSA-N 4-methylpyridine Chemical compound CC1=CC=NC=C1 FKNQCJSGGFJEIZ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000012065 filter cake Substances 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 238000000862 absorption spectrum Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- URLKBWYHVLBVBO-UHFFFAOYSA-N Para-Xylene Chemical group CC1=CC=C(C)C=C1 URLKBWYHVLBVBO-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 238000002329 infrared spectrum Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- IMRWILPUOVGIMU-UHFFFAOYSA-N 2-bromopyridine Chemical compound BrC1=CC=CC=N1 IMRWILPUOVGIMU-UHFFFAOYSA-N 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 230000005389 magnetism Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229940078487 nickel acetate tetrahydrate Drugs 0.000 description 2
- OINIXPNQKAZCRL-UHFFFAOYSA-L nickel(2+);diacetate;tetrahydrate Chemical compound O.O.O.O.[Ni+2].CC([O-])=O.CC([O-])=O OINIXPNQKAZCRL-UHFFFAOYSA-L 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- FILKGCRCWDMBKA-UHFFFAOYSA-N 2,6-dichloropyridine Chemical compound ClC1=CC=CC(Cl)=N1 FILKGCRCWDMBKA-UHFFFAOYSA-N 0.000 description 1
- MBTGBRYMJKYYOE-UHFFFAOYSA-N 2,6-difluoropyridine Chemical compound FC1=CC=CC(F)=N1 MBTGBRYMJKYYOE-UHFFFAOYSA-N 0.000 description 1
- JWTZSVLLPKTZJP-UHFFFAOYSA-N 2-bromo-6-chloropyridine Chemical compound ClC1=CC=CC(Br)=N1 JWTZSVLLPKTZJP-UHFFFAOYSA-N 0.000 description 1
- ZIDIKYIZXMYHAW-UHFFFAOYSA-N 2-bromo-6-fluoropyridine Chemical compound FC1=CC=CC(Br)=N1 ZIDIKYIZXMYHAW-UHFFFAOYSA-N 0.000 description 1
- LXOHKRGLGLETIJ-UHFFFAOYSA-N 2-chloro-6-fluoropyridine Chemical compound FC1=CC=CC(Cl)=N1 LXOHKRGLGLETIJ-UHFFFAOYSA-N 0.000 description 1
- NVKLTRSBZLYZHK-UHFFFAOYSA-N 4-tert-butylcalix[4]arene Chemical compound C1C(C=2O)=CC(C(C)(C)C)=CC=2CC(C=2O)=CC(C(C)(C)C)=CC=2CC(C=2O)=CC(C(C)(C)C)=CC=2CC2=CC(C(C)(C)C)=CC1=C2O NVKLTRSBZLYZHK-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 1
- 229910003298 Ni-Ni Inorganic materials 0.000 description 1
- 229910021586 Nickel(II) chloride Inorganic materials 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- JVSIBACDAOCZBA-UHFFFAOYSA-N [2-chloro-6-[2,6-di(propan-2-yl)phenyl]phenyl]-dicyclohexylphosphane Chemical group ClC=1C(=C(C=CC=1)C1=C(C=CC=C1C(C)C)C(C)C)P(C1CCCCC1)C1CCCCC1 JVSIBACDAOCZBA-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005865 alkene metathesis reaction Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012718 coordination polymerization Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 description 1
- QMMRZOWCJAIUJA-UHFFFAOYSA-L nickel dichloride Chemical compound Cl[Ni]Cl QMMRZOWCJAIUJA-UHFFFAOYSA-L 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 238000001225 nuclear magnetic resonance method Methods 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 125000002743 phosphorus functional group Chemical group 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- UYCAUPASBSROMS-AWQJXPNKSA-M sodium;2,2,2-trifluoroacetate Chemical compound [Na+].[O-][13C](=O)[13C](F)(F)F UYCAUPASBSROMS-AWQJXPNKSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 230000005469 synchrotron radiation Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- OIASAVWSBWJWBR-UKTHLTGXSA-N trans-2-[3-(4-tert-butylphenyl)-2-methyl-2-propenylidene]malononitrile Chemical compound N#CC(C#N)=CC(/C)=C/C1=CC=C(C(C)(C)C)C=C1 OIASAVWSBWJWBR-UKTHLTGXSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G79/00—Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
Abstract
本发明涉及一种主链为金属元素的高分子及其制备方法和应用,一种主链为金属元素的高分子,包括主链和配体,所述主链为由通过化学键相连的金属原子组成,化学结构式满足以下通式:式中,n为重复单元数,n大于10;M为金属原子,M选自过渡金属中的一种或多种;所述主链上的金属原子通过配位键与配体相连。所述金属主链高分子的制备步骤包含:配体的合成以及金属主链高分子的合成。本发明所制备的金属主链高分子为未来设计新的功能高分子开辟了新的途径。
Description
技术领域
本发明涉及高分子材料领域,尤其是涉及一种主链为金属元素的高分子及其制备方法和应用。
背景技术
1920年,Hermann Staudinger在《德国化学会会志》上发表了一篇划时代的论文《论聚合》,提出“聚合反应是大量小分子依靠化学键结合形成大分子的过程”的假说,标志着高分子学科的建立。这个概念到30年代末逐步被学界接受,此后高分子科学得到了迅速发展,取得了一系列重要进展和突破。40年代开始,Paul J.Flory提出了高分子溶液理论,奠定了高分子物理的研究基础。50年代Karl Ziegler和Giulio Natta发展了配位聚合反应,合成等规聚乙烯和聚丙烯。60年代,Robert Bruce Merrifield提出了多肽的固相有机合成方法。Pierre-Gilles de Gennes成功地将研究简单体系中有序现象的方法推广到高分子、液晶等复杂体系。70年代开始,Alan J.Heeger、Alan G.MacDiarmid和HidekiShirakawa开始研究导电高分子并做出了奠基性工作。Robert H.Grubbs提出了烯烃复分解反应催化剂,在高分子合成上做出了重要贡献。
通过上述高分子学科从诞生到发展的重要事件,纵观过去100年高分子科学的发展历程,有机高分子都是以非金属原子作为主链的基本组成,高分子物理和高分子化学的理论都是建立在上述基础上。但是,迄今为止,金属主链高分子尚未见报道。
发明内容
本发明的目的就是为了克服上述现有技术存在的缺陷而提供一种主链为金属元素的高分子及其制备方法和应用,其主链由金属原子通过化学键连接而成,并通过配体的金属化反应制备得到,由于高分子主链中存在着化学键相连的金属原子,其在光、热、力、声、电、磁等方面可能有着独特的性质,从而在光电器件、能源信息、生物医用材料、超导材料等方面具有潜在的应用。
本发明的目的可以通过以下技术方案来实现:
一种主链为金属元素的高分子,包括主链和配体,
所述主链为由通过化学键相连的金属原子组成,化学结构式满足以下通式:
式中,n为重复单元数,n大于10;
M为金属原子,M选自过渡金属中的一种或多种;
所述主链上的金属原子通过配位键与配体相连。
进一步地,主链化学结构式为
进一步地,所述M选自铬、锰、铁、钴、镍、铜、铑、钯、银、铱、铂或金。
上述更进一步地,所述M选自镍、铑或钯。
进一步地,所述高分子的数均分子量超过3000。
上述更进一步地,所述配体中含有吡啶基、萘啶基、氨基、羟基、苯基、巯基、羧基、共轭双键或磷基中的一种或多种基团。
上述更进一步地,所述配体含有吡啶或氨基基团。
上述更进一步地,所述配体含有吡啶或氨基基团时,高分子结构式如下:
式中,n为重复单元数,n大于10。
本发明还提供一种主链为金属元素的高分子的制备方法,具体步骤如下:
S1、合成配体:将聚合单体通过聚合反应相连得到配体基元,再通过偶联反应将多个配体基元与模板化合物相连接得到相应的配体;
S2、合成金属主链高分子:将步骤S1中合成的配体与金属盐化合物在加热时进行金属化反应,得到相应的金属主链高分子。
进一步地,当所述配体选自含有吡啶基基团时,步骤S1中,所述聚合单体为氨基吡啶和卤代氨基吡啶。
上述更进一步地,所述氨基吡啶为2-氨基吡啶。
上述更进一步地,所述卤代氨基吡啶选自2-氟-6-氨基吡啶、2-溴-6-氨基吡啶、2-氯-6-氨基吡啶、2-碘-6-氨基吡啶、2-溴-4-烷基-6-氨基吡啶、2-氯-4-烷基-6-氨基吡啶、2-氟-4-烷基-6-氨基吡啶或2-氟-4-烷基-6-氨基吡啶,优选为2-溴-6-氨基吡啶、2-氯-6-氨基吡啶或2-氟-6-氨基吡啶。
上述更进一步地,所述氨基吡啶和卤代氨基吡啶的比例为1:(6-80),优选为1:(8-16)。
进一步地,步骤S1中,合成配体具体步骤为,将聚合单体溶于有机溶剂中,在氮气保护下,在钯催化剂、有机磷配体和碱催化下聚合得到配体基元;
将杯芳烃、二溴吡啶和碱溶于有机溶剂中,在氮气保护下,加热偶联得到模板化合物;
将配体基元和模板化合物溶解在有机溶剂中,在氮气保护下,在钯催化剂、有机磷配体和碱催化下加热偶联得到相应的配体。
上述更进一步地,所述配体基元为聚氨基吡啶。
上述更进一步地,所述有机溶剂选自甲苯、吡啶、甲基吡啶、二氧六环、四氢呋喃、N,N-二甲基甲酰胺、N-甲基吡咯烷酮或二甲苯,优选为甲苯、吡啶或4-甲基吡啶。
上述更进一步地,所述钯催化剂选自三(二亚苄基丙酮)二钯、醋酸钯、(2-二环己基膦-3,6-二甲氧基-2',4',6'-三异丙基-1,1'-联苯)[2-(2-氨基乙基苯基)]氯化钯、氯(2-二环己基膦基2”,6”-二异丙基-1,1”-联苯)[2-(2-氨基乙基苯基)]钯(II)或二氯[1,1'-二(二苯基膦)二茂铁]钯,优选为三(二亚苄基丙酮)二钯、醋酸钯或二氯[1,1'-二(二苯基膦)二茂铁]钯。
上述更进一步地,所述有机磷配体选自1,3-双(二苯基磷)丙烷、1,1'-联萘-2,2'-双二苯膦、2-二环己基膦-2',4',6'-三异丙基联苯或二环己基[3,6-二甲氧基-2',4',6'-三异丙基[1,1'-联苯]-2-基]膦,优选为1,3-双(二苯基磷)丙烷、1,1'-联萘-2,2'-双二苯膦或2-二环己基膦-2',4',6'-三异丙基联苯。
上述更进一步地,所述碱选自叔丁醇钾、碳酸铯、酸钾、叔丁醇钠、二异丙基乙胺、碳酸钠或碳酸钾,优选为叔丁醇钾或碳酸铯。
上述更进一步地,所述杯芳烃选自杯[4]芳烃、4-烷基杯[4]芳烃或4-磺酰杯[4]芳烃,优选为叔丁基杯[4]芳烃。
上述更进一步地,所述二溴吡啶选自2,6-二溴吡啶、2,6-二氯吡啶、2-溴-6-氯吡啶、2,6-二氟吡啶、2-氟-6-氯吡啶或2-氟-6溴吡啶。
进一步地,步骤S2中,所述金属盐化合物选自碱金属的醋酸盐、氯化盐、溴化盐、硫酸盐或三氟乙酸盐。
上述更进一步地,步骤S1中合成的配体与金属盐化合物的质量比为1:(1-5),优选为1:(1-4)。
进一步地,步骤S2中,金属化反应是在有机溶剂存在下进行的,有机溶剂选自二甲基亚砜、萘或N-甲基吡咯烷酮。
此外,本发明还提供一种主链为金属元素的高分子的应用,将上述高分子应用于光电材料、生物医用材料或超导材料。
与现有技术相比,本发明有益效果如下:
(1)本发明创造性地提出并合成出一种新的聚合物,其分子主链由通过化学键连接的金属原子构成;
(2)本制备方法简便高效;通过调控氨基吡啶和卤代氨基吡啶的比例和金属原子的种类,可以获得具有不同金属和不同长度的金属主链高分子,为未来设计新的功能高分子开辟了新的途径。
附图说明
图1为本发明中金属主链高分子的基质辅助激光解吸电离飞行时间质谱(MALDI-TOF MS)图;
图2为本发明中金属主链高分子的扩展X射线吸收谱精细结构图;
图3为本发明中金属主链高分子的紫外–可见吸收光谱图。
具体实施方式
下面结合附图和具体实施例对本发明进行详细说明。
实施例1
一种主链为金属元素的高分子及其制备方法,具体步骤如下:
(1)配体的合成
a.配体基元聚氨基吡啶的合成
将2-氨基吡啶(1.00g,10.63mmol)和2-氨基-6-溴吡啶(14.70g,85.04mmol)溶解在甲苯(50mL)中;氮气保护下快速加入三二亚苄基丙酮二钯(366mg,0.39mmol)、1,3-双(二苯基磷)丙烷(327mg,0.78mmol)和叔丁醇钾(14.31g,127.56mmol),并在120℃下搅拌反应8h。减压蒸馏除去溶剂,过滤并先后用水、乙醇洗涤滤饼,干燥后得深黄色粉末4.67g,产率68%。
其核磁共振氢谱和红外谱图数据分别如下:
1H NMR(400MHz,DMSO-d6,ppm):δ9.35(s,-NH-),9.11–8.96(m,-NH-),8.78(s,-NH-),8.26–8.20(m,Py-H),7.94(d,Py-H),7.69–7.59(m,Py-H),7.59–7.41(m,Py-H),7.38–7.16(m,Py-H),7.13–7.07(m,Py-H),6.99–6.94(m,Py-H),6.89–6.81(m,Py-H),5.98(d,Py-H),5.62(m,-NH2)。
FTIR(KBr,cm-1):3477,3395,3197,3021,1603,1575,1507,1422,1249,1152,987,876,776,721,615,512。
其质谱数据如下:质谱(MALDI-TOF,m/z)理论值C5nH4n+3N2n[M+H]+(n):371.1(4),463.2(5),555.2(6),647.3(7),739.3(8),831.4(9),923.4(10);实测值:371.1,463.1,555.2,647.2,739.3,831.3,923.4。
b.模板化合物的合成
将氢化钠(3.12g,60%溶于石蜡中,0.078mol,10.00eq)分散在无水N,N-二甲基甲酰胺(150mL)中。在氮气保护下缓慢加入4-叔丁基杯[4]芳烃(5.00g,0.008mol,1.00eq),并于50℃下搅拌反应30分钟后加入2,6-二溴吡啶(29.13g,0.123mol,16.00eq),回流反应12h。待溶液冷却后,缓慢加入无水乙醇(10mL)淬灭反应,减压蒸馏除去溶剂,过滤并先后用乙醇和甲醇洗涤滤饼,再将滤饼用丙酮溶解过滤,二氯甲烷/甲醇重结晶得白色固体粉末3.41g,产率34%。其核磁共振氢谱、碳谱和红外谱图数据如下:
1H NMR(400MHz,CDCl3,ppm):δ7.60(dd,J=8.2,7.5Hz,4H),7.37(dd,J=8.2,0.7Hz,4H),7.08(dd,J=7.5,0.6Hz,4H),7.06(s,8H),3.78(d,J=13.0Hz,4H),3.16(d,J=13.0Hz,4H),1.18(s,36H)。
13C NMR(100MHz,CDCl3,ppm):δ164.2,147.2,145.6,140.8,138.5,133.9,125.6,121.1,110.4,34.2,31.4,31.1。
FTIR(KBr,cm-1):3077,3049,2962,2933,2903,2866,1577,1557,1480,1429,1405,1362,1301,1283,1261,1236,1192,1157,1137,1118,1076,983,924,892,879,871,821,785,740,724,670,641,540,442。
其高分辨质谱数据如下:高分辨质谱理论值C64H64Br4N4O4[M+H]+:1273.1706;实测值:1273.1714。
c.配体的合成
将步骤a合成的聚氨基吡啶(3.41g)和步骤b合成的模板化合物溴吡啶杯芳烃(400mg,0.31mmol)溶解于4-甲基吡啶(60mL)中。在氮气保护下快速加入三二亚苄基丙酮二钯(14.00mg,0.02mmol)、1,3-双(二苯基磷)丙烷(13.00mg,0.03mmol)和叔丁醇钾(278mg,2.48mmol),然后回流反应12h。反应结束后,将反应液倒入冰水中,过滤,然后先后用乙醇和二氯甲烷洗涤滤饼,干燥后得棕灰色粗产物2.12g,直接用于下一步反应。其质谱数据如下:
质谱(MALDI-TOF,m/z)理论值C54+5nH60+4nN2nO4Na(n):[M+Na]+(n):2821.3(24),2913.3(25),3005.3(26),3097.4(27),3190.4(28),3282.5(29),3374.5(30),3466.5(31),3558.6(32),3651.1(33),3743.3(34),3835.3(35),3927.7(36);实测值:2821.8,2913.9,3005.9,3098.0,3190.1,3282.1,3374.2,3466.2,3558.3,3650.8,3743.1,3835.0,3927.4。
(2)金属主链高分子的合成
将步骤(1)合成的配体(40mg)、四水合醋酸镍(80mg)和萘(10g)混合,并在氮气保护下,于200℃下搅拌反应24h。冷却至80℃时,加入石油醚过滤除去萘,再用二氯甲烷洗涤滤饼,所得滤液除去溶剂后得到金属主链高分子14.4mg,产率28%。
其红外谱图数据如下:
FTIR(KBr,cm-1):2953,2923,2852,1599,1583,1557,1410,1307,1257,1226,1194,1153,1126,1012,842,767,722,557。
其质谱数据如下:
质谱(MALDI-TOF,m/z)理论值C64+20n+5mCl0-1H68+12n+4mCl0-1N4+8n+2mNi1+2nO4[M]+(m,n):3516.4(1,5)3609.5(2,5),3700.5(3,5),3792.5(4,5),3884.6(5,5),3976.6(6,5),3997.4(1,6),4089.5(2,6),4182.5(3,6),4274.5(4,6),4479.3(5,6),4571.4(6,6);实测值:3515.9,3609.0,3700.0,3792.1,3884.1,3976.1,3996.9,4089.0,4182.1,4274.1,4479.0,4571.1。
实施例2
一种主链为金属元素的高分子及其制备方法,具体步骤如下:
(1)配体的合成
a.配体基元聚氨基吡啶的合成
将2-氨基吡啶(1.00g,10.63mmol)和2-氨基-6-氯吡啶(13.67g,106.30mmol)溶解在对二甲苯(80mL)中;氮气保护下快速加入醋酸钯(129mg,0.39mmol)、1,1'-联萘-2,2'-双二苯膦(485.69mg,0.78mmol)和碳酸铯(31.17g,127.56mmol),并在150℃下搅拌反应24h。减压蒸馏除去溶剂,加水超声后过滤,再先后用水、乙醇洗涤滤饼,干燥后得深黄色粉末4.87g,产率71%。
其核磁共振氢谱和红外谱图数据如下:
1H NMR(400MHz,DMSO-d6,ppm):δ9.35(s,-NH-),9.11–8.96(m,-NH-),8.78(s,-NH-),8.26–8.20(m,Py-H),7.94(d,Py-H),7.69–7.59(m,Py-H),7.59–7.41(m,Py-H),7.38–7.16(m,Py-H),7.13–7.07(m,Py-H),6.99–6.94(m,Py-H),6.89–6.81(m,Py-H),5.98(d,Py-H),5.62(m,-NH2)。
FTIR(KBr,cm-1):3477,3395,3197,3021,1603,1575,1507,1422,1249,1152,987,876,776,721,615,512.
其质谱数据如下:
质谱(MALDI-TOF,m/z)理论值C5nH4n+3N2n[M+H]+(n):463.2(5),555.2(6),647.3(7),739.3(8),831.4(9),923.4(10),1015.6(11);实测值:463.1,555.2,647.2,739.3,831.3,923.4,1015.5。
b.模板化合物的合成
制备工艺与实施例1步骤(1)中b.模板化合物的合成的相同。
c.配体的合成
将步骤a合成的聚氨基吡啶(3.41g)和步骤b合成的模板化合物溴吡啶杯芳烃(400mg,0.31mmol)溶解于N-甲基吡咯烷酮(50mL)中。在氮气保护下快速加入醋酸钯(6.85mg,0.03mmol)、1,3-双(二苯基磷)丙烷(30.04mg,0.06mmol)和叔丁醇钾(278mg,2.48mmol),然后回流反应24h。反应结束后,将反应液倒入冰水中,过滤,然后先后用乙醇和二氯甲烷洗涤滤饼,干燥后得棕灰色粗产物2.51g,直接用于下一步反应。
其质谱数据如下:
质谱(MALDI-TOF,m/z)理论值C54+5nH60+4nN2nO4Na[M+Na]+(n):2913.3(25),3005.3(26),3097.4(27),3190.4(28),3282.5(29),3374.5(30),3466.5(31),3558.6(32),3651.1(33),3743.3(34),3835.3(35),3927.7(36),4019.9(37);实测值:2913.9,3005.9,3098.0,3190.1,3282.1,3374.2,3466.2,3558.3,3650.8,3743.1,3835.0,3927.4,4019.9。
(2)金属主链高分子的合成
将步骤(1)合成的配体(60mg)和氯化镍(83mg)溶解于无水二甲基亚砜(40mL)中,并在氮气保护下,于180℃下搅拌反应12h。反应结束后,减压蒸馏除去溶剂,再用二氯甲烷溶解过滤,除去溶剂后得到金属主链高分子27mg,产率35%。
其红外谱图数据如下:
FTIR(KBr,cm-1):2953,2923,2852,1599,1583,1557,1410,1307,1257,1226,1194,1153,1126,1012,842,767,722,557。
其质谱数据如下:
质谱(MALDI-TOF,m/z)理论值C64+20n+5mCl0-1H68+12n+4mCl0-1N4+8n+2mNi1+2nO4[M]+(m,n):3218.5(3,4),3310.6(4,4),3402.6(5,4),3494.6(6,4),3516.4(1,5),3609.5(2,5),3700.5(3,5),3792.5(4,5),3884.6(5,5),3976.6(6,5),3997.4(1,6),4089.5(2,6),4182.5(3,6),4274.5(4,6),4479.3(5,6),4571.4(6,6),4663.5(3,7),4755.5(4,7);实测值:3218.0,3310.1,3402.1,3494.2,3515.9;3609.0;3700.0,3792.1,3884.1,3976.1,3996.9,4089.0,4182.1,4274.1,4479.0,4571.1,4663.2,4755.2。
实施例3
一种主链为金属元素的高分子及其制备方法,具体步骤如下:
(1)配体的合成
a.配体基元聚氨基吡啶的合成
将2-氨基吡啶(1.00g,10.63mmol)和2-氨基-6-氟吡啶(32.44g,148.82mmol)溶解4-甲基吡啶(100mL)中;氮气保护下快速加入1,1'-双二苯基膦二茂铁二氯化钯(399mg,0.39mmol)、1,1'-联萘-2,2'-双二苯膦(679mg,1.09mmol)和碳酸铯(43.66g,133.94mmol),并在150℃下搅拌反应8h。减压蒸馏除去溶剂,过滤并先后用水、乙醇洗涤滤饼,干燥后得深黄色粉末4.67g,产率68%。
其核磁共振氢谱和红外谱图数据如下:
1H NMR(400MHz,DMSO-d6,ppm):δ9.35(s,-NH-),9.11–8.96(m,-NH-),8.78(s,-NH-),8.26–8.20(m,Py-H),7.94(d,Py-H),7.69–7.59(m,Py-H),7.59–7.41(m,Py-H),7.38–7.16(m,Py-H),7.13–7.07(m,Py-H),6.99–6.94(m,Py-H),6.89–6.81(m,Py-H),5.98(d,Py-H),5.62(m,-NH2)。
FTIR(KBr,cm-1):3477,3395,3197,3021,1603,1575,1507,1422,1249,1152,987,876,776,721,615,512。
其质谱数据如下:
质谱(MALDI-TOF,m/z)理论值C5nH4n+3N2n[M+H]+(n):463.2(5),555.2(6),647.3(7),739.3(8),831.4(9),923.4(10),1015.6(11),1107.6(12);实测值:463.1,555.2,647.2,739.3,831.3,923.4,1015.5,1107.6。
b.模板化合物的合成
制备工艺与实施例1步骤(1)中模板化合物的合成的相同。
c.配体的合成
将步骤a合成的聚氨基吡啶(5.32g)和步骤b合成的模板化合物溴吡啶杯芳烃(400mg,0.31mmol)溶解于对二甲苯(100mL)中。在氮气保护下快速加入醋酸钯(13.72.00mg,0.06mmol)、1,3-双(二苯基磷)丙烷(13.00mg,0.03mmol)和叔丁醇钾(278mg,2.48mmol),然后回流反应36h。反应结束后,将反应液倒入冰水中,过滤,然后先后用乙醇和二氯甲烷洗涤滤饼,干燥后得棕灰色粗产物2.35g,直接用于下一步反应。
其质谱数据如下:
质谱(MALDI-TOF,m/z)理论值C54+5nH60+4nN2nO4Na[M+Na]+(n):2913.3(25),3005.3(26),3097.4(27),3190.4(28),3282.5(29),3374.5(30),3466.5(31),3558.6(32),3651.1(33),3743.3(34),3835.3(35),3927.7(36),4019.9(37),4112.2(38),4202.8(39),4295.8(40);实测值:2913.9,3005.9,3098.0,3190.1,3282.1,3374.2,3466.2,3558.3,3650.8,3743.1,3835.0,3927.4,4019.9,4111.9,4202.6,4295.6。
(2)金属主链高分子的合成
将步骤(1)合成的配体(40mg)和四水合醋酸镍(120mg)加入到20mL无水DMSO中,并在氮气保护下,于200℃下搅拌反应24h。反应结束后,减压蒸馏除去溶剂,再用二氯甲烷溶解,过滤,除去溶剂后得到金属主链高分子18.51mg,产率36%。
其红外谱图数据如下:
FTIR(KBr,cm-1):2953,2923,2852,1599,1583,1557,1410,1307,1257,1226,1194,1153,1126,1012,842,767,722,557。
其质谱数据如下:
质谱(MALDI-TOF,m/z)理论值C64+20n+5mCl0-1H68+12n+4mCl0-1N4+8n+2mNi1+2nO4[M]+(m,n):3516.4(1,5),3609.5(2,5),3700.5(3,5),3792.5(4,5),3884.6(5,5),3976.6(6,5),3997.4(1,6),4089.5(2,6),4182.5(3,6),4274.5(4,6),4479.3(5,6),4571.4(6,6),4755.5(4,7),4961.4(1,8),5053.4(2,8),5145.5(3,8),5386.1(0,9);实测值:3515.9,3609.0,3700.0,3792.1,3884.1,3976.1,3996.9,4089.0,4182.1,4274.1,4479.0,4571.1,4755.2,4961.1,5053.1,5145.2,5385.8。
经检测,所合成金属主链高分子结构如上式所示,其分子量可达5000以上(图1,实施例3)。如图2所示(实施例1),在金属主链高分子的扩展X射线吸收谱精细结构图中,处有一吸收峰,和参比镍箔的吸收峰/>相一致,表明合成的金属主链高分子中存在Ni-Ni金属键;其在二氯甲烷中紫外可见吸收带在370-450nm波长范围内,最大吸收波长为414nm(图3,实施例2)。
其中:分子结构测试使用核磁共振法,用氘代二甲基亚砜做溶剂;分子量使用Bruker McriOTOF11高分子质谱仪和AB SCIEX 5800基质辅助激光解吸电离飞行时间质谱仪测试(反式-2-[3-(4-叔丁基苯基)-2-甲基-2-亚丙烯基]丙二腈为基质,三氟乙酸钠为钠盐);X射线吸收谱使用北京同步辐射装置(BSRF)的1W1B束线测试;紫外可见吸收光谱使用Perkin-Elmer Lambda750紫外可见分光光度计测试。
所合成金属主链高分子的主链中存在着化学键相连的金属原子,其在光、热、力、声、电、磁等方面的可能有着独特的性质,从而将作为光电材料、生物医用材料、超导材料等方面进行应用。
以上所述仅为本发明的优选实施例而已,并不用于限制本发明,尽管参照前述实施例对本发明进行了详细的说明,对于本领域的技术人员来说,其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (6)
1.一种主链为金属元素的高分子,其特征在于,包括主链和配体,
所述主链为由通过化学键相连的金属原子组成,化学结构式满足以下通式:
,式中,n为重复单元数,n大于10;
M选自铬、锰、铁、钴、镍、铜、铑、钯、银、铱、铂或金;
所述主链上的金属原子通过配位键与配体相连;
所述高分子的数均分子量超过3000;
合成配体具体步骤为:将聚合单体溶于有机溶剂中,在氮气保护下,在钯催化剂、有机磷配体和碱催化下聚合得到配体基元,将杯芳烃、二溴吡啶和碱溶于有机溶剂中,在氮气保护下,加热偶联得到模板化合物,将配体基元和模板化合物溶解在有机溶剂中,在氮气保护下,在钯催化剂、有机磷配体和碱催化下加热偶联得到相应的配体;
所述配体基元为聚氨基吡啶,
所述有机溶剂选自甲苯、吡啶、甲基吡啶、二氧六环、四氢呋喃、N,N-二甲基甲酰胺、N-甲基吡咯烷酮或二甲苯,
所述钯催化剂选自三(二亚苄基丙酮)二钯、醋酸钯、(2-二环己基膦-3,6-二甲氧基-2',4',6'-三异丙基-1,1'-联苯)[2-(2-氨基乙基苯基)]氯化钯、氯(2-二环己基膦基2'',6''-二异丙基-1,1''-联苯)[2-(2-氨基乙基苯基)]钯(II)或二氯[1,1'-二(二苯基膦)二茂铁]钯,
所述有机磷配体选自1,3-双(二苯基磷)丙烷、1,1'-联萘-2,2'-双二苯膦、2-二环己基膦-2',4',6'-三异丙基联苯或二环己基[3,6-二甲氧基-2',4',6'-三异丙基[1,1'-联苯]-2-基]膦,
所述碱选自叔丁醇钾、碳酸铯、叔丁醇钠、二异丙基乙胺、碳酸钠或碳酸钾,
所述杯芳烃选自杯[4]芳烃、4-烷基杯[4]芳烃或4-磺酰杯[4]芳烃,
所述二溴吡啶选自2,6-二溴吡啶。
2.根据权利要求1所述的一种主链为金属元素的高分子,其特征在于,所述配体结构式如下:
,式中,n为重复单元数,n大于10。
3.一种如权利要求1-2中任一所述主链为金属元素的高分子的制备方法,其特征在于,具体步骤如下:
S1、合成配体:将聚合单体通过聚合反应相连得到配体基元,再通过偶联反应将多个配体基元与模板化合物相连接得到相应的配体;
S2、合成金属主链高分子:将步骤S1中合成的配体与金属盐化合物在加热时进行金属化反应,得到相应的金属主链高分子。
4.根据权利要求3所述的一种主链为金属元素的高分子的制备方法,其特征在于,
步骤S1中,所述聚合单体为氨基吡啶和卤代氨基吡啶;
所述氨基吡啶为2-氨基吡啶,
所述卤代氨基吡啶选自2-氟-6-氨基吡啶、2-溴-6-氨基吡啶、2-氯-6-氨基吡啶、2-碘-6-氨基吡啶、2-溴-4-烷基-6-氨基吡啶、2-氯-4-烷基-6-氨基吡啶、2-氟-4-烷基-6-氨基吡啶或2-氟-4-烷基-6-氨基吡啶,
所述氨基吡啶和卤代氨基吡啶的比例为1:(6-80)。
5.根据权利要求3所述的一种主链为金属元素的高分子的制备方法,其特征在于,步骤S2中,所述金属盐化合物选自碱金属的醋酸盐、氯化盐、溴化盐、硫酸盐或三氟乙酸盐,步骤S1中合成的配体与金属盐化合物的质量比为1:(1-5),
金属化反应是在有机溶剂存在下进行的,有机溶剂选自二甲基亚砜、萘或N-甲基吡咯烷酮。
6.一种如权利要求1-2中任一所述主链为金属元素的高分子的应用,其特征在于,将所述高分子应用于光电材料、生物医用材料或超导材料。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211377822.2A CN115746309B (zh) | 2022-11-04 | 2022-11-04 | 一种主链为金属元素的高分子及其制备方法和应用 |
PCT/CN2023/092389 WO2024093176A1 (zh) | 2022-11-04 | 2023-05-05 | 一种主链为金属元素的高分子及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211377822.2A CN115746309B (zh) | 2022-11-04 | 2022-11-04 | 一种主链为金属元素的高分子及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115746309A CN115746309A (zh) | 2023-03-07 |
CN115746309B true CN115746309B (zh) | 2023-08-29 |
Family
ID=85357920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211377822.2A Active CN115746309B (zh) | 2022-11-04 | 2022-11-04 | 一种主链为金属元素的高分子及其制备方法和应用 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN115746309B (zh) |
WO (1) | WO2024093176A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115746309B (zh) * | 2022-11-04 | 2023-08-29 | 复旦大学 | 一种主链为金属元素的高分子及其制备方法和应用 |
CN115894958B (zh) * | 2022-12-19 | 2023-11-07 | 复旦大学 | 一种具有精准长度的金属主链高分子及其合成方法与应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004323675A (ja) * | 2003-04-24 | 2004-11-18 | Sumitomo Seika Chem Co Ltd | ポリアミノピリジン類の製造方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11202009303SA (en) * | 2018-03-29 | 2020-10-29 | Toray Industries | Polymetalloxane, composition, cured film, member, electronic component, fiber, binder for ceramic molding, cured film production method, and fiber production method |
JPWO2022202398A1 (zh) * | 2021-03-22 | 2022-09-29 | ||
CN115746309B (zh) * | 2022-11-04 | 2023-08-29 | 复旦大学 | 一种主链为金属元素的高分子及其制备方法和应用 |
-
2022
- 2022-11-04 CN CN202211377822.2A patent/CN115746309B/zh active Active
-
2023
- 2023-05-05 WO PCT/CN2023/092389 patent/WO2024093176A1/zh unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004323675A (ja) * | 2003-04-24 | 2004-11-18 | Sumitomo Seika Chem Co Ltd | ポリアミノピリジン類の製造方法 |
Also Published As
Publication number | Publication date |
---|---|
CN115746309A (zh) | 2023-03-07 |
WO2024093176A1 (zh) | 2024-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN115746309B (zh) | 一种主链为金属元素的高分子及其制备方法和应用 | |
Schubert et al. | Metallo‐supramolecular graft copolymers: a novel approach toward polymer‐analogous reactions | |
Liu et al. | Silver (I) coordination polymers of fluorescent oligo (phenylenevinylene) with π− π Stackings: luminescence and conductivity | |
US5091502A (en) | Tetraketone porphyrin monomers and the porphyrin-based polymers thereof | |
Qiu et al. | Nickel-catalyzed suzuki polycondensation for controlled synthesis of ester-functionalized conjugated polymers | |
CN114106353B (zh) | 四种以邻菲罗啉并咪唑衍生物为配体的聚合配合物及其制备方法与用途 | |
Wu et al. | One pot synthesis of poly (3-hexylthiophene)-block-poly (hexadecyloxylallene) by sequential monomer addition | |
US20020198346A1 (en) | Vinyl-phenyl pyridine monomers and polymers prepared thereform | |
He et al. | Ni (II) and Pd (II) complexes bearing benzocyclohexane–ketoarylimine for copolymerization of norbornene with 5‐norbornene‐2‐carboxylic ester | |
CN107129490B (zh) | 一种含呋喃-2-亚甲醛结构的席夫碱铁配合物吸波材料及制备方法 | |
Chan et al. | Synthesis and photosensitizing properties of conjugated polymers that contain chlorotricarbonyl bis (phenylimino) acenaphthene rhenium (I) complexes | |
Wu et al. | Using an isolation chromophore to further improve the comprehensive performance of nonlinear optical (NLO) dendrimers | |
Qi et al. | A Series of Bisamide‐Substituted Diacetylenes Exhibiting a Terminal Alkyl Odd/Even Parity Effect on Mechanoactivated Photopolymerization | |
Kaya et al. | New conjugated azomethine oligomers obtained from bis-(hydroxyphenyl) methylenediamine via oxidative polycondensation and their complexes with metals | |
Yuan et al. | Synthesis and characterization of conjugated polymers containing first row transition metal complexes | |
Mandal et al. | Photochemical [2+ 2] polymerization of metal–organic gels of a rigid and angular diene with silver-salts of diverse anions: selective dye-sorption and luminescence by xerogels | |
Zhou et al. | Synthesis and characterization of tris (2, 2′‐bipyridine) ruthenium‐cored star‐shaped polymers via RAFT polymerization | |
CN115894958B (zh) | 一种具有精准长度的金属主链高分子及其合成方法与应用 | |
CN114957697B (zh) | 基于[2+2]光环加成反应的光刺激响应配位聚合物及其制备和应用 | |
Kherroub et al. | Highly conductive and soluble polymer synthesized by copolymerization of thiophene with para-methoxybenzaldehyde using clay catalyst | |
Murray et al. | Synthesis, structure and electrochemistry of mononuclear and dinuclear ruthenium–thiophenecarboxylate complexes | |
Kim et al. | Synthesis and properties of polyimides derived from 9, 10‐dialkyloxy‐1, 2, 3, 4, 5, 6, 7, 8‐octahydro‐2, 3, 6, 7‐anthracenetetracarboxylic 2, 3: 6, 7‐dianhydrides | |
Takahashi et al. | Studies on polyyne polymers containing transition metals in the main chain. IV. Polymer synthesis by oxidative coupling of transition metal‐bis (acetylide) complexes | |
JP5191682B2 (ja) | 側鎖にアントラセン残基を有するフェノール誘導体及びその製造方法 | |
Zhenghe et al. | Synthesis, conductivity and photosensitivity of 2-D conjugated polymers of metalporphyrazine with sulfur bridges |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |